These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34131942)

  • 21. A randomized, placebo- and moxifloxacin-controlled thorough QT study of umeclidinium monotherapy and umeclidinium/vilanterol combination in healthy subjects.
    Kelleher D; Tombs L; Preece A; Brealey N; Mehta R
    Pulm Pharmacol Ther; 2014 Oct; 29(1):49-57. PubMed ID: 25020273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the effects of bitopertin (RG1678) on cardiac repolarization: a thorough corrected QT study in healthy male volunteers.
    Hofmann C; Banken L; Hahn M; Swearingen D; Nagel S; Martin-Facklam M
    Clin Ther; 2012 Oct; 34(10):2061-71. PubMed ID: 22980315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Thorough QT Study of the Combination Glecaprevir + Pibrentasvir on Cardiac Repolarization in Healthy Subjects.
    Oberoi RK; Zhao W; Rosebraugh M; Mensa F; Wang H; Liu W
    Clin Ther; 2020 Jul; 42(7):1317-1329. PubMed ID: 32622784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiating the Effect of an Opioid Agonist on Cardiac Repolarization From µ-Receptor-mediated, Indirect Effects on the QT Interval: A Randomized, 3-way Crossover Study in Healthy Subjects.
    Darpo B; Zhou M; Bai SA; Ferber G; Xiang Q; Finn A
    Clin Ther; 2016 Feb; 38(2):315-26. PubMed ID: 26749217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, crossover, placebo- and moxifloxacin-controlled study to evaluate the effects of bosutinib (SKI-606), a dual Src/Abl tyrosine kinase inhibitor, on cardiac repolarization in healthy adult subjects.
    Abbas R; Hug BA; Leister C; Sonnichsen D
    Int J Cancer; 2012 Aug; 131(3):E304-11. PubMed ID: 22065400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of an Effect of Supratherapeutic Dose of Venlafaxine on Cardiac Repolarization in Healthy Subjects.
    Abbas R; Riley S; Nepal S; Bachinsky M; Lee KC; Chappell PB; Damle B
    Clin Pharmacol Drug Dev; 2022 Jan; 11(1):100-111. PubMed ID: 34242472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of the glucosylceramide synthase inhibitor lucerastat on cardiac repolarization: results from a thorough QT study in healthy subjects.
    Mueller MS; Sidharta PN; Voors-Pette C; Darpo B; Xue H; Dingemanse J
    Orphanet J Rare Dis; 2020 Oct; 15(1):303. PubMed ID: 33109218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thorough QT Study To Evaluate the Effect of Zoliflodacin, a Novel Therapeutic for Gonorrhea, on Cardiac Repolarization in Healthy Adults.
    Newman LM; Kankam M; Nakamura A; Conrad T; Mueller J; O'Donnell J; Osborn BL; Gu K; Saviolakis GA
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0129221. PubMed ID: 34606332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Retosiban on Cardiac Repolarization in a Randomized, Placebo- and Positive-controlled, Crossover Thorough QT/QTc Study in Healthy Men and Women.
    Stier B; Fossler M; Liu F; Caltabiano S
    Clin Ther; 2015 Jul; 37(7):1541-54. PubMed ID: 26138866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Phase 1, double-blind, 4-period crossover study to investigate the effects of pomalidomide on QT interval in healthy male subjects.
    Mondal SA; Assaf M; Liu L; O'Mara E
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):251-8. PubMed ID: 26754679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Randomized, Double-Blind, Placebo- and Positive-Controlled, 4-Period Crossover Study of the Effects of Solriamfetol on QTcF Intervals in Healthy Participants.
    Zomorodi K; Chen D; Lee L; Swearingen D; Carter LP
    Clin Pharmacol Drug Dev; 2021 Apr; 10(4):404-413. PubMed ID: 32935460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A thorough QT study of guanfacine.
    Martin P; Satin L; Kahn RS; Robinson A; Corcoran M; Purkayastha J; Youcha S; Ermer JC
    Int J Clin Pharmacol Ther; 2015 Apr; 53(4):301-16. PubMed ID: 25109412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of sugammadex doses up to 32 mg/kg alone or in combination with rocuronium or vecuronium on QTc prolongation: a thorough QTc study.
    de Kam PJ; van Kuijk J; Prohn M; Thomsen T; Peeters P
    Clin Drug Investig; 2010; 30(9):599-611. PubMed ID: 20568829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study.
    Teerlink JR; Clarke CP; Saikali KG; Lee JH; Chen MM; Escandon RD; Elliott L; Bee R; Habibzadeh MR; Goldman JH; Schiller NB; Malik FI; Wolff AA
    Lancet; 2011 Aug; 378(9792):667-75. PubMed ID: 21856480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, single-dose, crossover study of the effects of ulotaront on electrocardiogram intervals in subjects with schizophrenia.
    Tsukada H; Milanovic SM; Darpo B; Xue H; Xiong K; Tripp E; Lennek L; Worden M; Hopkins SC; Galluppi GR
    Clin Transl Sci; 2023 Jun; 16(6):1063-1074. PubMed ID: 36949248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Midostaurin does not prolong cardiac repolarization defined in a thorough electrocardiogram trial in healthy volunteers.
    del Corral A; Dutreix C; Huntsman-Labed A; Lorenzo S; Morganroth J; Harrell R; Wang Y
    Cancer Chemother Pharmacol; 2012 May; 69(5):1255-63. PubMed ID: 22294470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Cefiderocol, a Siderophore Cephalosporin, on QT/QTc Interval in Healthy Adult Subjects.
    Sanabria C; Migoya E; Mason JW; Stanworth SH; Katsube T; Machida M; Narukawa Y; Den Nagata T
    Clin Ther; 2019 Sep; 41(9):1724-1736.e4. PubMed ID: 31378318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects.
    Dixon R; Job S; Oliver R; Tompson D; Wright JG; Maltby K; Lorch U; Taubel J
    Br J Clin Pharmacol; 2008 Sep; 66(3):396-404. PubMed ID: 18662287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thorough QT study of the effects of vildagliptin, a dipeptidyl peptidase IV inhibitor, on cardiac repolarization and conduction in healthy volunteers.
    He YL; Zhang Y; Serra D; Wang Y; Ligueros-Saylan M; Dole WP
    Curr Med Res Opin; 2011 Jul; 27(7):1453-63. PubMed ID: 21609207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of therapeutic and supratherapeutic oral doses of nomegestrol acetate (NOMAC)/17β-estradiol (E2) on QTcF intervals in healthy women: results from a randomized, double-blind, placebo- and positive-controlled trial.
    de Kam PJ; van Kuijk J; Lillin O; Post T; Thomsen T
    Clin Drug Investig; 2014 Jun; 34(6):413-20. PubMed ID: 24777591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.